- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.03. | Paragonix's donor kidney perfusion system completes commercial flight | ||
| 03.03. | Pliant discontinues late-stage lung disease trial for lead asset after safety review | ||
| 03.03. | Boston Scientific snags renal denervation developer SoniVie for $540M | ||
| 03.03. | Neumora halts trial of depression drug, rethinks 2 others to apply lessons from phase 3 failure | ||
| 03.03. | Sanofi bounces midstage ILT2 asset back to Biond Biologics after $125M bet | ||
| 03.03. | Lexicon feels the pain as midphase non-opioid data underwhelm investors | ||
| 03.03. | Frazier arms Callio with $187M series A to fly Hummingbird's HER2 dual payload ADC to clinic | ||
| 03.03. | Takeda's $300M bet on Protagonist's blood cancer drug pays off with phase 3 win | ||
| 03.03. | Novo bets up to $354M per target on Gensaic's tissue-selective delivery tech | ||
| 03.03. | AbbVie pays Gubra $350M to make late play for obesity space | ||
| 28.02. | ElevateBio gene therapy lowers levels of toxic protein in mice with Huntington's disease | ||
| 28.02. | Cryoablation developer Adagio Medical lays off staff, refocuses on US study | ||
| 28.02. | BridgeBio's KRAS-focused cancer spinout backs SPAC as path to Nasdaq | ||
| 28.02. | Praxis flouts phase 3 futility finding, forging ahead with tremor trial despite interim setback | ||
| 28.02. | Mission changes, shuttering lab to focus on clinical assets | ||
| 28.02. | Nxera sells APAC license to lupus drug to Viatris for $10M upfront | ||
| 27.02. | Vir, awaiting 'functional cure' data for hep B combo, won't take treatment forward alone | ||
| 27.02. | Trump HHS re-evaluating Biden administration's $590M bird flu vaccine contract with Moderna: Bloomberg | ||
| 27.02. | Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal | ||
| 27.02. | Kallyope links oral obesity combo to 3% weight loss, rejigs pipeline as migraine asset advances | ||
| 27.02. | Vertex axes Verve gene editing pact amid shift in R&D priorities | ||
| 27.02. | Silence slows phase 3 plans for cardio drug, as Hansoh opts out of $1.3B biobucks collab | ||
| 26.02. | Health tech firm partners with UK medical recordkeeper to match patients with clinical trials | ||
| 26.02. | Wearable defibrillator maker Kestra Medical plots $150M IPO | ||
| 26.02. | Quest Diagnostics to claim Fresenius Medical Care's kidney dialysis testing portfolio |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
